A Phase 1 Trial of Autologous Monocytes Stimulated Ex Vivo With Sylatron® (Peginterferon Alfa-2b) and Actimmune® (Interferon Gamma-1b) for Intra-Peritoneal Administration in Recurrent Ovarian Cancer

Journal of Translational Medicine - United Kingdom
doi 10.1186/s12967-018-1569-5

Related search